These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease. Liu J; Ma KL; Zhang Y; Wu Y; Hu ZB; Lv LL; Tang RN; Liu H; Ruan XZ; Liu BC Int J Biochem Cell Biol; 2015 Apr; 61():8-19. PubMed ID: 25622557 [TBL] [Abstract][Full Text] [Related]
4. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia. Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609 [TBL] [Abstract][Full Text] [Related]
6. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease. Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy. Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009 [TBL] [Abstract][Full Text] [Related]
8. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. Ruan XZ; Moorhead JF; Fernando R; Wheeler DC; Powis SH; Varghese Z J Am Soc Nephrol; 2003 Mar; 14(3):593-600. PubMed ID: 12595494 [TBL] [Abstract][Full Text] [Related]
9. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting. Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines. Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199 [TBL] [Abstract][Full Text] [Related]
12. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. Wang Y; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR J Lipid Res; 2005 Nov; 46(11):2377-87. PubMed ID: 16106051 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression. Zhang N; Lei J; Lei H; Ruan X; Liu Q; Chen Y; Huang W Exp Cell Res; 2015 Aug; 336(1):33-42. PubMed ID: 26033364 [TBL] [Abstract][Full Text] [Related]
15. [Inflammation enhances the accumulation of lipid in ApoE/SRA/CD36 KO mice liver]. Yan F; Huang AL; Xu ZE; Ruan XZ; Chen YX Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):366-70. PubMed ID: 20510003 [TBL] [Abstract][Full Text] [Related]
16. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
17. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype. Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781 [TBL] [Abstract][Full Text] [Related]
18. Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells. Byun HW; Hong EM; Park SH; Koh DH; Choi MH; Jang HJ; Kae SH; Lee J Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):65-73. PubMed ID: 24463082 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes. Liu W; Qin L; Yu H; Lv F; Wang Y J Gastroenterol Hepatol; 2014 Mar; 29(3):614-22. PubMed ID: 24219083 [TBL] [Abstract][Full Text] [Related]
20. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. Abildayeva K; Jansen PJ; Hirsch-Reinshagen V; Bloks VW; Bakker AH; Ramaekers FC; de Vente J; Groen AK; Wellington CL; Kuipers F; Mulder M J Biol Chem; 2006 May; 281(18):12799-808. PubMed ID: 16524875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]